Peptidomimetic Long-Acting Growth Hormone-Releasing Hormone Agonists Promote Tissue Perfusion in Hindlimb Ischemia

> 24 h). Subcutaneous administration of selected peptides in mice with ischemic hindlimb enhanced blood perfusion and preservation of limb function. They also promoted endothelial regeneration and collateral vessel formation, enhancing vascular remodeling and tissue repair. In vitro, the peptides enhanced the angiogenic potential of endothelial cells, primarily through activation of the ERK signaling pathway. Our findings lay a strong foundation for the development of long-acting GHRH-R agonists with promising therapeutic potential for the treatment of vascular and regenerative disease.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2026-04-13
DOI
https://doi.org/10.1021/acs.jmedchem.5c03408
Primary Topic
Growth Hormone and Insulin-like Growth Factors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Peptidomimetic Long-Acting Growth Hormone-Releasing Hormone Agonists Promote Tissue Perfusion in Hindlimb Ischemia

Xiaoke Niu, Peng Teng, Haodong Shao, Bo Wang et al.
Journal of Medicinal Chemistry
Growth Hormone and Insulin-like Growth Factors
article

Peptidomimetic Long-Acting Growth Hormone-Releasing Hormone Agonists Promote Tissue Perfusion in Hindlimb Ischemia

Xiaoke Niu, Peng Teng, Haodong Shao, Bo Wang, Jianhua Zhang, Xing Su, H-T Yu, Yinyin Wu, Zhitao Guo, Meng Chen, Mengyu Mao, Jiayan Luo
article en

Abstract

> 24 h). Subcutaneous administration of selected peptides in mice with ischemic hindlimb enhanced blood perfusion and preservation of limb function. They also promoted endothelial regeneration and collateral vessel formation, enhancing vascular remodeling and tissue repair. In vitro, the peptides enhanced the angiogenic potential of endothelial cells, primarily through activation of the ERK signaling pathway. Our findings lay a strong foundation for the development of long-acting GHRH-R agonists with promising therapeutic potential for the treatment of vascular and regenerative disease.

Journal of Medicinal ChemistryVol. 69(8)
Nanjing University of Chinese Medicine (CN), Nantong University (CN), Affiliated Hospital of Nantong University (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Jinhua Academy of Agricultural Sciences (CN), Zhejiang Lab (CN), Drug Discovery Laboratory (Norway) (NO), Kindeva Drug Delivery (United States) (US), Zhejiang University (CN), Guangzhou Medical University (CN)
National Natural Science Foundation of China, Zhejiang University, Natural Science Foundation of Zhejiang Province
Zero hunger
Openalex Percentile: Top 25%
Growth Hormone and Insulin-like Growth Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.